title: Human papilloma virus and cervical preinvasive disease.
abstract: Cervical cancer lesions represent a major threat to the health of the women worldwide. Human Papillomavirus (HPV) is responsible for 99.7% of cervical cancer cases, the infectious etiology giving the possibility of preventing cervical cancer by vaccination. The most aggressive HPV types are 16 and 18, which cause about 70% of cases of invasive cancer. The vaccination is recommended to the girls aged 11-12. The diagnosis and the treatment of cervical preinvasive disease allow the doctor to prevent the development of the invasive disease.
authors.affiliation: Filantropia Hospital of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
authors.forename: Gheorghe
authors.initials: G
authors.lastname: Peltecu
authors.forename: Maria
authors.initials: M
authors.lastname: Bari
authors.forename: George
authors.initials: G
authors.lastname: Lancu
authors.forename: Florian
authors.initials: F
authors.lastname: Popa
mesh_terms: D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000145:classification / Q000276:immunology / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000150:complications* / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000601:surgery / Q000821:virology*; D014626:Vaginal Smears; D014765:Viral Vaccines / Q000627:therapeutic use; D014860:Warts / Q000276:immunology / Q000473:pathology / Q000821:virology*
chemical_list: D014765:Viral Vaccines